Key clinical point: Influenza vaccination is safe for most patients with autoimmune neuromuscular disorders, according to a survey of neurologists.
Major finding: Neurologists approach influenza vaccination conservatively in patients with Guillain-Barré syndrome.
Study details: A web-based survey of U.S. neurologists.
Disclosures: The study was supported by the department of neurology at Yale University, New Haven, Conn.; there was no external funding. Dr. Nowak had no relevant disclosures.
Litchman T et al. AANEM 2019, Abstract 16.